Zhifei Biologics plans CNY 6bn bond issuance

Chongqing Zhifei Biological Products (SZSE:300122) has announced its intention to issue corporate bonds with a total value not exceeding CNY 6 billion. This decision was made at the Sixth Meeting of the Sixth Board of Directors. The proceeds from the bond issuance are earmarked for investment in technological innovation, construction and operation activities, debt restructuring, and replenishing working capital. The company plans to seek shareholder approval for the bond issuance and to authorize the board chairman to manage specifics based on market conditions. The bond structure will offer both public and private placement options. Zhifei intends to seek listing of the bonds on the Shenzhen Stock Exchange. An extraordinary shareholders' meeting has been scheduled for July 14, 2025, to approve the bond issuance plan and related authorizations.